| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|---|---|---|---|---|---|
Operating activities | ||||||
Net loss | ||||||
668,629 | -21,138 | -33,150 | -52,761 | -37,483 | -21,724 | -9,927 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation | ||||||
2,361 | 2,433 | 1,484 | 698 | 699 | 664 | 784 |
Share-based compensation expense | ||||||
3,358 | 1,660 | 1,750 | 5,573 | 4,407 | 7,020 | 739 |
Gain from Janssen Transaction | ||||||
675,000 | - | - | - | - | - | - |
Amount Held in Escrow | ||||||
-75,000 | - | - | - | - | - | - |
Deferred Tax Asset | ||||||
444 | - | - | - | - | - | - |
Gain on disposal of property and equipment | ||||||
- | - | - | - | 157 | 0 | 0 |
Other non-cash adjustments | ||||||
- | - | 401 | - | 0 | - | - |
Changes in operating assets and liabilities: | ||||||
Prepaid expenses and other current assets | ||||||
472 | -372 | -1,041 | 617 | 1,579 | -38 | 252 |
Accounts payable | ||||||
496 | -78 | -2,700 | -981 | 840 | 1,068 | 103 |
Accrued expenses | ||||||
2,888 | 229 | -2,470 | - | - | - | - |
Deferred revenue | ||||||
4,500 | - | - | - | - | - | - |
Other taxes payable | ||||||
49,361 | - | - | - | - | - | - |
Accrued expenses | ||||||
- | - | - | 2,066 | -52 | 1,234 | -326 |
Deferred rent | ||||||
-3 | -15 | -5 | 7 | 17 | 0 | -29 |
Tax payable | ||||||
1,056 | - | - | - | - | - | - |
Net cash used in operating activities | ||||||
-18,270 | -16,537 | -33,649 | -46,015 | -33,308 | -11,700 | -8,908 |
Investing activities | ||||||
Purchase of property and equipment | ||||||
204 | 122 | 1,405 | 4,746 | 2,322 | 1,397 | 59 |
Cash received from Janssen Transaction | ||||||
675,000 | - | - | - | - | - | - |
Expenditures on building construction | ||||||
- | - | - | 9,168 | 8,070 | 0 | 0 |
Net cash used in investing activities | ||||||
674,796 | -122 | -1,405 | -13,914 | -10,392 | -1,397 | -59 |
Financing activities | ||||||
Issuance of common stock and warrants, net | ||||||
38,062 | - | 32,620 | - | - | - | - |
Issuance of common stock and warrants, net | ||||||
- | - | - | 1,808 | 75,712 | 63,374 | 12,045 |
Issuance of common stock under stock option plan | ||||||
3,732 | 201 | 703 | 1,136 | 1,348 | 150 | 0 |
Collection of subscription receivable | ||||||
302 | - | - | - | - | - | - |
Collection of subscription receivable | ||||||
- | - | - | - | 410 | 0 | 0 |
Deferred offering costs | ||||||
- | - | - | - | - | 324 | 0 |
Net cash provided by (used in) financing activities | ||||||
42,096 | 201 | 33,323 | 2,944 | 77,470 | 63,200 | 12,045 |
Effect of foreign exchange rate on cash and cash equivalents | ||||||
149 | 513 | -825 | 258 | -48 | -18 | -1 |
Net change in cash and cash equivalents | ||||||
698,771 | -15,945 | -2,556 | -56,727 | 33,722 | 50,085 | 3,077 |
Supplemental Information: | ||||||
Accrued purchases of property and equipment | ||||||
- | - | - | 148 | 940 | 19 | - |
Accrued expenditures on building construction | ||||||
- | - | - | 439 | 1,416 | 224 | - |
Subscription receivable | ||||||
- | 200 | - | - | - | - | - |